| Cat. No. | Product Description | Application | Quantity | Price | Cart |
|---|---|---|---|---|---|
| 152 403 | Ca2+ channel R-type α-1E, rabbit, polyclonal, affinity purifiedaffinity | WB IHC | 50 µg | $380.00 |   |
| 152 404 | Ca2+ channel R-type α-1E, Guinea pig, polyclonal, antiserumantiserum | WB | 100 µl | $370.00 | |
| 152 411 | Ca2+ channel R-type α-1E, mouse, monoclonal, purified IgG IgG K.O. | WB | 100 µg | $420.00 | |
| 152 503 | Ca2+ channel T-type α-1G, rabbit, polyclonal, affinity purifiedaffinity | WB IHC | 50 µg | $380.00 | |
| 152 505 | Ca2+ channel T-type α-1G, Guinea pig, polyclonal, affinity purifiedaffinity | WB IHC | 50 µg | $465.00 | |
| 475 002 | CaBP5, rabbit, polyclonal, antiserumantiserum | WB IHC | 200 µl | $360.00 | |
| 475 003 | CaBP5, rabbit, polyclonal, affinity purifiedaffinity | WB IHC IHC-P (FFPE) | 50 µg | $460.00 | |
| 214 002 | Calbindin D28k, rabbit, polyclonal, antiserumantiserum | WB IP ICC IHC IHC-P (FFPE) | 200 µl | $360.00 | |
| 214 003 | Calbindin D28k, rabbit, polyclonal, affinity purifiedaffinity | WB IP ICC IHC IHC-P (FFPE) Clarity | 50 µg | $460.00 | |
| 214 004 | Calbindin D28k, Guinea pig, polyclonal, antiserumantiserum | WB IP ICC IHC IHC-P (FFPE) | 100 µl | $400.00 | |
| 214 005 | Calbindin D28k, Guinea pig, polyclonal, affinity purifiedaffinity | WB IP ICC IHC IHC-P (FFPE) | 50 µg | $470.00 | |
| 214 006 | Calbindin D28k, chicken, polyclonal, IgY fractionIgY fraction | WB IP ICC IHC IHC-P (FFPE) IHC-Fr | 200 µl | $370.00 |  |
| 214 008 | Calbindin D28k, rabbit, monoclonal, recombinant IgGrecombinant IgG | WB ICC IHC IHC-P (FFPE) | 50 µg | $420.00 | |
| 214 009 | Calbindin D28k, chicken, monoclonal, recombinant IgYrecombinant IgY | WB ICC IHC IHC-P (FFPE) | 50 µg | $420.00 | |
| 214 011 | Calbindin D28k, mouse, monoclonal, purified IgG IgG | WB IP ICC IHC IHC-P (FFPE) Clarity | 100 µg | $425.00 | |
Certificates
ISO 9001 2015 Quality Management System and Green Lab Platinum certification level for sustaining laboratory processes.
Newsletter
Sign up for our newsletter and get the latest updates and news.
